Table VIII.
Association between the expression of miR-200a-3p and clinicopathological parameters of gastric cancer.
| Variable | Cases, n (%) | Expression of miR-200a-3p, median ± range | P-value |
|---|---|---|---|
| Gender | 0.048* | ||
| Male | 32 (57) | 1.178±0.377 | |
| Female | 24 (43) | 2.456±0.527 | |
| Age, years | 0.376 | ||
| ≤50 | 18 (32) | 2.143±0.674 | |
| >50 | 38 (68) | 1.528±0.351 | |
| Tumor size, cm | 0.909 | ||
| ≤5 | 31 (55) | 1.759±0.470 | |
| >5 | 25 (45) | 1.684±0.430 | |
| Degree of differentiation | 0.458 | ||
| Well and moderately | 17 (30) | 1.885±0.394 | |
| Poorly | 39 (70) | 1.361±0.552 | |
| TNM stage | 0.377 | ||
| I/II | 27 (48) | 2.023±0.568 | |
| III/IV | 29 (52) | 1.449±0.325 | |
| Lymph-node status | 0.003* | ||
| No metastasis | 6 (11) | 4.379±0.597 | |
| Metastasis | 50 (89) | 1.407±0.280 |
miR, microRNA; TNM, tumor node metastasis.